Rekvina Laboratories P/B Ratio

Current P/B Ratio
14.36
High Valuation
Very High - Significant premium, high growth expectations or speculative

Rekvina Laboratories P/B ratio. Rekvina Laboratories (VINRKLB) P/B ratio is 14.36 (High), book value per share ₹-3.33 — Very High - Significant premium, high growth expectations or speculative. Analyse VINRKLB FII DII holdings to track promoter, FII and institutional holdings.

Current Valuation Metrics

P/B Ratio 14.36
Current Price ₹50.50
Book Value/Share ₹-3.33
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹-1 Cr
Share Capital ₹3 Cr
Reserves & Surplus ₹-4 Cr
Outstanding Shares 3,000,000
Book Value per Share ₹-3.33

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 0.0
Sector Median 0.61
Sector Rank #11 of 50
Sector Percentile 22.0%

VINRKLB P/B Ratio — Valuation Insights & Book Value Analysis

Rekvina Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 14.36 (High). View VINRKLB yearly price range for the annual high/low range and current price position.

  • Stock appears overvalued with PB of 14.36, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of 0.0

VINRKLB vs Healthcare Peers — P/B Ratio Comparison

Rekvina Laboratories P/B 14.36 vs Healthcare average 0.0, median 0.61 — range -6.55–1.07.

Sector Average
0.0
Sector Median
0.61
Lowest P/B
-6.55
Highest P/B
1.07
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹35 Low
Krebs Biochemicals & Ind… KREBSBIO -0.8 ₹147 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.19 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low